Send us a text This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industr...
All content for IPWatchdog Unleashed is the property of Gene Quinn and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industr...
Settled Expectations: When is a Patent Safe from Challenge at the PTAB?
IPWatchdog Unleashed
44 minutes
3 months ago
Settled Expectations: When is a Patent Safe from Challenge at the PTAB?
This week on IPWatchdog Unleashed my conversation is with Kevin McNish, who is a registered patent attorney who represents clients in inter partes reviews (IPR), post-grant reviews (PGR), ex parte reexaminations, and other proceedings before the Patent Trial and Appeal Board (PTAB) at the United States Patent and Trademark Office (USPTO). I invited McNish to join us for a conversation about PTAB practice and how it has evolved over the last several months, and to specifically discuss one of t...
IPWatchdog Unleashed
Send us a text This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industr...
